Profile

Websites
favorite icon ResearchGate


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Edwards CV, Hassan H, Yildirim C, Ferri G, Verma KP, Murray Horwitz ME, Fillmore NR, Munshi NC. Peripheral blood monocyte count is a dynamic prognostic biomarker in multiple myeloma. Blood Adv. 2023 Feb 28; 7(4):482-490.View Related Profiles. PMID: 36409606; PMCID: PMC9979755; DOI: 10.1182/bloodadvances.2022008021;
     
  2. La J, DuMontier C, Hassan H, Abdallah M, Edwards C, Verma K, Ferri G, Dharne M, Yildirim C, Corrigan J, Gaziano JM, Do NV, Brophy MT, Driver JA, Munshi NC, Fillmore NR. Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System. Pharmacoepidemiol Drug Saf. 2023 May; 32(5):558-566.View Related Profiles. PMID: 36458420; PMCID: PMC10448707; DOI: 10.1002/pds.5579;
     
  3. Hassan H, Ammad Ud Din M, Jamshed S, Bress J, Mustafa SS. Effect of Ibrutinib on Hmphocytic Leukemia: a Single-Center Experience. Hematol Oncol Stem Cell Ther. 2022 Dec 23; 15(4):208-212. PMID: 34391729
     
  4. Hassan H, Verma K, Ferri G, Brauneis D, Quillen K, Sloan JM, Sanchorawala V, Edwards CV. Modified High-Dose versus High-Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis. Transplant Cell Ther. 2022 Nov; 28(11):761.e1-761.e7.View Related Profiles. PMID: 35970300
     
  5. Hassan H, Anwer F, Javaid A, Hashmi H. Progress in research: Daratumumab improves treatment outcomes of patients with AL amyloidosis. Crit Rev Oncol Hematol. 2021 Sep; 165:103435. PMID: 34343658
     
  6. Hassan H, Szalat R. Genetic Predictors of Mortality in Patients with Multiple Myeloma. Appl Clin Genet. 2021; 14:241-254.View Related Profiles. PMID: 33953598; PMCID: PMC8092627; DOI: 10.2147/TACG.S262866;
     
  7. Hughes DM, DeMari S, Hassan H, Sanchorawala V, Sloan JM. Safety, Tolerability, and Efficacy of Selinexor in a Patient With Relapsed Light Chain (AL) Amyloidosis. Clin Lymphoma Myeloma Leuk. 2021 05; 21(5):e460-e463.View Related Profiles. PMID: 33716055
     
  8. Usman RM, Razzaq F, Akbar A, Farooqui AA, Iftikhar A, Latif A, Hassan H, Zhao J, Carew JS, Nawrocki ST, Anwer F. Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance. Asia Pac J Clin Oncol. 2021 Jun; 17(3):193-208. PMID: 32970929; DOI: 10.1111/ajco.13449;
     
  9. Majeed A, Sagar F, Latif A, Hassan H, Iftikhar A, Darouiche RO, Mohajer MA. Does antimicrobial coating and impregnation of urinary catheters prevent catheter-associated urinary tract infection? A review of clinical and preclinical studies. Expert Rev Med Devices. 2019 Sep; 16(9):809-820. PMID: 31478395; DOI: 10.1080/17434440.2019.1661774;
     
  10. Iftikhar A, Hassan H, Iftikhar N, Mushtaq A, Sohail A, Rosko N, Chakraborty R, Razzaq F, Sandeep S, Valent JN, Kanate AS, Anwer F. Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development. Antibodies (Basel). 2019 May 24; 8(2). PMID: 31544840; PMCID: PMC6640719; DOI: 10.3390/antib8020034;
     
Showing 10 of 11 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.


Contact for Mentoring: